These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Zurier RB; Damjanov I; Sayadoff DM; Rothfield NF Arthritis Rheum; 1977; 20(8):1449-56. PubMed ID: 144506 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631 [TBL] [Abstract][Full Text] [Related]
5. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. Starke C; Steinkasserer A; Voll RE; Zinser E Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695 [TBL] [Abstract][Full Text] [Related]
6. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus. Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477 [TBL] [Abstract][Full Text] [Related]
7. The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse. Clark WF; Parbtani A; McDonald JW; Taylor N; Reid BD; Kreeft J Clin Nephrol; 1987 Dec; 28(6):288-94. PubMed ID: 2450713 [TBL] [Abstract][Full Text] [Related]
12. Recombinant interleukin-2 therapy of systemic lupus erythematosus in the New Zealand black/New Zealand white mouse. Owen KL; Shibata T; Izui S; Walker SE J Biol Response Mod; 1989 Aug; 8(4):366-74. PubMed ID: 2666586 [TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandin E1 on the production of IgM and IgG class anti-dsDNA antibodies in NZB/W F1 mice. Yoshikawa T; Suzuki H; Sugiyama E; Tunru IS; Ikemoto M; Hori T; Matsui S; Yamashita N; Kobayashi M J Rheumatol; 1993 Oct; 20(10):1701-6. PubMed ID: 8295181 [TBL] [Abstract][Full Text] [Related]
14. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model. Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H Lupus; 2007; 16(5):335-41. PubMed ID: 17576735 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion. Fantone JC; Kunkel RG; Kinnes DA Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454 [TBL] [Abstract][Full Text] [Related]
16. Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. Hurd ER; Johnston JM; Okita JR; MacDonald PC; Ziff M; Gilliam JW J Clin Invest; 1981 Feb; 67(2):476-85. PubMed ID: 6450777 [TBL] [Abstract][Full Text] [Related]
17. Effect of PGE1 treatment on in vitro thymocyte function of normal and autoimmune mice. Whittum-Hudson J; Ballow M; Zurier RB Immunopharmacology; 1988; 16(2):71-8. PubMed ID: 2974449 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus. McMurray RW; Elbourne KB; Lagoo A; Lal S J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431 [TBL] [Abstract][Full Text] [Related]
19. T-cell tolerance induction is normal in the (NZB x NZW)F1 murine model of systemic lupus erythematosus. Wither J; Vukusic B Immunology; 2000 Mar; 99(3):345-51. PubMed ID: 10712663 [TBL] [Abstract][Full Text] [Related]
20. An unexpected potent positive chronotropic effect of (15S)-15-methyl-prostaglandin E1 in the isolated guinea-pig right atria. Uzun O; Akarsu ES; Türker RK Prostaglandins Leukot Med; 1985 Apr; 18(1):1-7. PubMed ID: 3858887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]